Pharmacodynamic and Pharmacokinetic Evaluation of a New Transdermal Delivery System with a Time-Dependent Release of Glyceryl Trinitrate-Reference-Cited by-同舟云学术

Pharmacodynamic and Pharmacokinetic Evaluation of a New Transdermal Delivery System with a Time-Dependent Release of Glyceryl Trinitrate

Published:1992-01 Issue:1 Volume:32 Page:77-84
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Wiegand A.,Bonn R.,Trenk D.,Jähnchen E.,Bauer K.-H.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/j.1552-4604.1992.tb03792.x/fullpdf

Reference25 articles.

1. Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route;Shaw;Am Heart J,1984

2. Rapidly developing tolerance to transdermal nitroglycerin in congestive heart failure;Jordan;Ann Intern Med,1986

3. Rapid attenuation of hemodynamic efficacy of continuous transcutaneous nitroglycerin in severe heart failure; Lack of cross-tolerance to isosorbide dinitrate;Packer;Circulation,1984

4. Transdermal nitroglycerin in angina pectoris.;Parker;Am J Cardiol,1984

5. Anti-anginal effects of nitroglycerin patches;Reichek;Am J Cardiol,1984

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Introduction: Utility of Mathematical Models in Drug Development and Delivery;Drug Delivery Approaches;2021-07-27

2. Glycerintrinitrat [MAK Value Documentation in German language, 2011];The MAK-Collection for Occupational Health and Safety;2012-01-31

3. Pharmacodynamic Evaluation: Cardiovascular Methodologies;Drug Discovery and Evaluation: Methods in Clinical Pharmacology;2011

4. Nitric Oxide Is Released Into Circulation With Whole-Body, Periodic Acceleration * *Dr. Sackner is Chief Executive Officer and Chairman Board of Directors, Non-Invasive Monitoring Systems, Inc., and owns approximately 37% of Non-Invasive Monitoring Systems, Inc. shares. He is also a member of the Board of Directors, Vivometrics, Inc., Ventura CA. Ms. Gummels owns approximately 0.2% of Non-Invasive Monitoring Systems shares. Dr. Adams is a member of the Scientific Advisory Board and owns approximately 0.1% of Non-Invasive Monitoring Systems shares.;Chest;2005-01

5. Clinical Pharmacokinetics and Pharmacodynamics of Glyceryl Trinitrate and its Metabolites;Clinical Pharmacokinetics;2003